Other Issues

Browse Other Issues Content

The American Cleaning Institute (ACI) and the Consumer Healthcare Products Association (CHPA) request that FDA withdraw its Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19).

Apr 28, 2021

CHPA applauds FDA’s recent emergency use authorization for a number of over-the-counter (OTC) nonprescription self-testing products for COVID-19.

Apr 2, 2021

CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.

Mar 23, 2021

The new law returns PSE to OTC status allowing consumers to purchase 3.6 grams of PSE per day, up to 7.2 grams per month.

Mar 17, 2021

In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).

Mar 17, 2021

Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.

Feb 4, 2021

CHPA, along with a wide coalition of organizations, co-signed a joint press release in support of the re-introduction of this bipartisan CBD bill.

Feb 4, 2021

Cindy Sanders discusses a recent study examining the growing interest in OTC access to oral contraceptives.

Jan 8, 2021

CHPA’s “Insights with Impact” series features Cindy Sanders, Co-Publisher/Managing Editor of Nashville Medical News, who discusses the growing interest in over-the-counter access to oral contraceptives.

Jan 8, 2021

Filter Results